Vanda Pharmaceuticals, Inc. (VNDA)
8.27
-0.64
(-7.18%)
USD |
NASDAQ |
Mar 02, 13:24
Vanda Pharmaceuticals EPS Diluted (Quarterly) : -2.389 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Axsome Therapeutics, Inc. | -0.5641 |
| AnaptysBio, Inc. | 0.5208 |
| Gossamer Bio, Inc. | -0.2115 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -141.19M |
| Revenue (Quarterly) | 57.22M |
| Total Expenses (Quarterly) | 198.40M |
| Enterprise Value | 275.32M |
| Gross Profit Margin (Quarterly) | 86.65% |
| Profit Margin (Quarterly) | -246.8% |
| Earnings Yield | -45.18% |
| Normalized Earnings Yield | -45.18 |